Glucophage (metformin) is a prescription medication that is licensed to treat type 2 diabetes (also known as noninsulin-dependent diabetes or adult-onset diabetes). This side effect can be fairly serious for patients with type II diabetes, as they may need to lose weight to treat their condition. To demonstrate bioequivalence of a 2.5 mg saxagliptin/850 mg metformin fixed dose combination (FDC) tablet relative to the 2.5 mg saxagliptin tablet and 850 mg metformin (Glucophage Marketed by Merck-Serono) tablet co-administered to healthy subjects in the fasted and fed condition.
Objectives: This study investigated the clinical efficacy and safety of metformin hydrochloride sustained-release (SR) tablet (II) produced by Dulening and the original metformin hydrochloride tablet produced by Glucophage in the treatment of type 2 diabetes mellitus (T2DM). To demonstrate bioequivalence of a 2.5 mg saxagliptin/500 mg metformin (glucophage) immediate release (IR) fixed dose combination (FDC) tablet to the 2.5 mg saxagliptin tablet and rentry.co 500 mg metformin IR tablet co-administered to healthy subjects in a fasted and in a fed state.
If you are not on Glucophage SR which is the slow release version, then you should ask to be changed to that as it should overcome most stomach upset problems